Two-Week stool test may forecast ulcerative colitis Flare-Ups a year in advance

This study is testing whether changes in two stool markers — a fecal immunochemical test (qFIT) and calprotectin (FC) — measured two weeks after starting standard therapy can predict whether people with ulcerative colitis will relapse or need stronger medication within a year. Researchers will follow 100 adults with active UC who have never taken biologic drugs, collecting stool samples at weeks 0, 2, and 4. The goal is to see if a drop of more than 50% or a return to normal levels in both markers can serve as an early warning sign, helping doctors tailor treatment sooner.